Their study provided evidence that both TGF-β1 and VEGF are significantly upregulated in patients with muscle-invasive bladder cancer (MIBC), supporting their role as critical mediators of tumor progression within the evolving bladder cancer microenvironment. This evidence concerns the gene VEGFA and urinary bladder carcinoma.